Light Mode
$2.03 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.03, $0.07 below the day’s high of $2.10
+0.02 (+1.00%) / 6M
Momentum, market sentiment, and recent alerts
SERA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -44.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.